Abstract
The well-chosen title of this conference implies that emotional behavior can be coded in a simple alphabet consisting of a relatively small number of neuromodulators and synaptic transmitters0 One of the main difficulties in deciphering this code is that we know only a few of its “letters” [catecholamines (CA), serotonin (5HT), acetylcholine, etc,]. Toman and Sabelli (cf. Sabelli, 1964) proposed that not only is there a multiplicity of transmitters of various presynaptic origins, but there are also many endogenous chemicals that regulate neural function by modulating synaptic transmission mediated by other chemicals and by acting upon extrasynaptic membranes. 2-Phenylethyl amine (PEA) may represent one example of this concept of neuromodulators.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baldessarini, R.J., and Vogt, M., 1971, The uptake and subcellular distribution of aromatic amines in the brain of the rat, J. Neurochem. 18: 2519.
Biel, J.H., Nuhfer, P.A., Hoya, W.K., Leiser, H.A., and Abood, L.G., 1962, Cholinergic blockage as an approach to the development of new psychotropic agents, Ann. J. Y. Acad. Sei. 96: 251.
Boulton, A.A., and Milward, L., 1971, Separation, detection and quantitative analysis of urinary 3-phenyl ethylamine, Chrom. 57: 287.
Brunner, E.L., and Sabel1i, H.C., 1971, The effect of 5-hydroxy-indoleacetic acid on the action potential of the frog ventricle, Pharmacologist 13: 267.
Carlsson, A., Fuxe, K., and Ungerstedt, U., 1968, The effect of imipramine on central 5-hydroxytryptami ne neurons, J. Pharm. Pharmacol. 20: 150.
Coppen, A., 1967, The biochemistry of affective disorders, Brit. Psychiat. 113: 1237.
Costa, E., and Neff, N.H., 1966, Isotopic and non-isotopic measure-ments of the rate of catecholamine biosynthesis, Jjn “Biochemistry and Pharmacology of the Basal Ganglia,” (E. Costa, L.J. Cote, and M.D. Tahr, eds.), pp. 141–156, Raven Press, New York.
Creveling, C.R., Daly, J.W., Witkop, B., and Udenfriend, S., 1962, Substrates and inhibitors of dopamine-β-oxidase, Biochem. Biophys. Acta 64: 125.
Creveling, C.R., Daly, J.W., Tokuyama, T., and Witkop, B., 1968, The combined use of a-methyltyrosine and threo-dihydroxypheny1serine-selective reduction of dopamine levels in the central nervous system, Biochem. Pharmacology 17: 65.
Dewhurst, W.G., 1968, New theory of cerebral amine function and its clinical application, Nature 218: 1130.
Edwards, D.J., and Blau, K., 1972, Analysis of phenylethylamines in biological tissues by gas-liquid chromatography with electron-capture detection, Analyt. Biochem. 45: 387.
Edwards, D.J., and Blau, K., 1973, Phenylethylamines in brain and liver of rats with experimentally induced phenylketonuria-1ike characteristics, Biochem, J. 132: 95.
Ehinger, B., and Myhrberg, H.E., 1971, Neijronal localization of dopamine, noradrenaline, and 5-hydroxytryptamine in the central and peripheral nervous system of Lumbricus terrestris (L.), Histochemie 28: 265.
Feldstein, A., Chang, G.H., and Kuchorki, J.M., 1970, Tryptophol, 5-hydroxytryptophol and 5-methoxytryptophol induced sleep in mice, Life Sciences 9: 323.
Fischer, E., Ludmer, R.I., and Sabelli, H.C., 1967, The antagonism of phenyl ethyl amine to catecholamines on mouse motor activity, Acta Physiol. Lat. Amer. 17: 15.
Fischer, E., Heller, B., and Miro, A.N., 1968, β-Phenylethyl amine in human urine, Arzneim. Forsch. 18: 1486.
Fischer, E., Spatz, H., Heller, B., and Reggiani, H., 1972a, Phenyl ethylamine content of human urine and rat brain, its alteration in pathological conditions and after drug administration, Experientia 28: 307.
Fischer, E., Spatz, H., Saavedra, J.M., Reggiani, H., Miro, A.H., and Heller, B., 1972b, Urinary elimination of phenyl ethyl amine, Biol. Psychiat. 5: 139.
Fuxe, K., Grobecker, H., and Jonsson, J., 1967, The effect of β -phenyl ethyl amine on central and peripheral monoamine-containing neurons, Europ. J. Pharmacol. 2: 202.
Giardina, W.J., Sabel1i, H.C., and Aderman, M., 1970, Non-hydroxylated and deaminated derivatives of catecholamines on mouse exploratory behavior: A hypothesis of antidepressive action, Proc. 78th Ann. Conv. Amer, Psychol. Assoc., Miami Beach, Sept. 3–8, pp. 811–812.
Giardina, W.J., Pedemonte, W.A., and Sabel1i, H.C., 1973, lontophoretic study of the effect of norepinephrine and 2-phenylethylamine on single cortical neurons, Life Science 12: 153.
Goodwin, F.K., 1971, Psychiatric side effects of Levodopa in man, J.A.M.A. 218: 1915.
Goodwin, F.K., Murphy, D.L., Brodie, H.K.H., and Bunney, Jr., W.E., 1970, L-Dopa, catecholamines and behavior: a clinical and biochemical study in depressed patients, Biol. Psychiat. 2: 341.
Grundfest, H., 1957, General problems of drug actions on bioelectrical phenomena, Ann. JN.Y. Acad. Sci. 66: 537.
Hartman, B.K., and Udenfriend, S., 1972, The application of immunological techniques to the study of enzymes regulating catecholamine synthesis and degradation, Pharmacol. Rev. 24: 311.
Himwich, H.E., and Alpers, H.S., 1970, Psychophamiacology, in “Annual Reviews of Pharmacology,” vol. 10, (H.W. Elliot, W.C. Cutting, and R.H. Dreisback, eds.), PP. 313–334, Annual Reviews, Inc., Palo Alto, California.
Holtz, P., 1966, Introductory remarks, Pharmacol. Review 18: 85.
Inwang, E.E., Sugerman, J.H., De Martini, W.J., Mosnaim, A.D., and Sabel1i, H.C., 1972, Ultraviolet spectrophotometric determination of β-phenylethyl amine-like substances in biological samples and its possible correlation with depression, presented at the Annual Convention of the Society of Biological Psychiatry, Dallas, April 28–30, 1972.
Inwang, E.E., Madabuike, U.P., and Mosnaim, A.D., 1973a, Evidence for the excretion of 2-phenylethyl amine glucuronide in human urine, Experientia (in press).
Inwang, E.E., Mosnaim, A.D., and Sabel1i, U.C., 1973b, Isolation and characterization of phenylethylamine and phenylethanolamîne from human braîn, J. Neurochem. 20: 1469.
Jackson, D.M., and Temple, D.M., 1970, g-Phenylethyl ami ne as a cardiotonic constituent of tissue extracts, Comp. Gen, Pharmac. 1: 155.
Jenkins, R.B., and Groh, R.H., 1970, Mental symptoms in Parkinsonian patients treated with L-DOPA, The Lancet 2: 177.
Jepson, J.B., Lovenberg, W., and Zaltzman, P., 1960, Amine metabolism studied in normal and Phenylketonurie humans by monoamine oxidase inhibition, Biochem. 74: 5.
Kety, S., 1970, Brain amines and affective disorders, in “Brain Chemistry and Mental Disease,” (B.T. Ho, and W.M. McIsaac, eds.), pp. 237–244, Plenum Press, New York.
Klaiber, E.L., Broverman, D.M., Vogel, W., Kobayashi, Y., and Moriarty, D., 1972, Effects of estrogen therapy on plasma MAO activity and EEG driving responses of depressed women, Amer. J. Psychiat. 128: 1492.
Kopin, I.J., 1968, Identification of “true” and “false” transmitters in psychopharmacology, Public Health Service Publication 1836, ( D.H. Effron, ed. ), Washington, pp. 57–60.
Loo, Y.H., 1967, Characterization of a new phenylalanine metabolite in phenylketonuria, J. Neurochem. 14: 813.
Maas, J.W., Fawcett, J., and Dekirmenjian, H., 1972, Catecholamine metabolism, depressive illness and drug response, Arch. Gen. Psychiat. 26: 252.
Mantegazza, P., and Riva, M., 1963, Amphetamine-1ike activity of g-phenylethyl amine, J. Pharm. 15: 472.
Marley, E., 1966, Behavioral and electrophysiological effects of catecholamines, Pharm. Rev. 18: 753.
Molinoff, B.P., Landsberg, L., and Axel rod, J., 1969, An enzymatic assay for octopamine and other (S-hydroxylated phenyl ethyl amines, Pharmac. Exp. Ther. 170: 253.
Mosnaim, A.D., and Inwang, E.E., 1973, A spectrophotometric method for the quantification of 2-phenylethyl amine in biological specimens, Anal. Biochem. (in press).
Mosnaim, A.D., and Sabelli, H.C., 1971, Quantitative determination of the brain levels of a 3-phenylethyl amine-like substance in control and drug-treated mice, Pharmacoloqist 13: 283.
Mosnaim, A.D., Inwang, E.E., and Sabel1i, H.C., 1972, Phenylethylamine-like substance(s) in mammalian brain and their increase by repeated electroshock seizures, presented at the Society for Neuroscience, Houston, October 8–11, 1972.
Mosnaim, A.D., Inwang, E.E., Sugerman, J.H., De Martini, W.J., and Sabelli, H.C., 1973a, Ultraviolet spectrophotometric determination of 2-phenylethyl amine in biological samples and its possible correlation with depression, Biological Psychiatry 6 (3): 235.
Mosnaim, A.D., Inwang, E.E., Sugerman, J.H., and Sabelli, H.C., 1973b, Identification of 2-phenylethyl amine in human urine by infrared and mass spectroscopy and its quantification in normal subjects and cardiovascular patients, Clinica Chimica Acta (in press).
Mosnaim, A.D., Sabelli, H.C., and Inwang, E.E., 1973c, The influence of psychotropic drugs on the levels of endogenous 2-phenylethyl- amine in brain, presented at the Society of Biological Psychiatry, Montreal, June 8–10, 1973.
Mosnaim, A.D., Whalley, C., Pedemonte, W.A., Vazquez, A.J., and Sabelli, H.C., 1973d, Further evidence for a role of 2-phenyl- ethylamine as a mediator for the stimulant action of β-tetra-hydrocannabinoi, to be presented at the Society for Neuroscience, San Diego, Nov. 1973.
Nakajima, T., Kakimoto, Y., and Sano, I., 1964, Formation of phenyl-ethylamine in mammalian tissues and its effect on motor activity in the mouse, J. Pharm. 143: 319.
Ng, L.K.Y., Lamprecht, F., Williams, R.B., and Kopin, I.J., 1973, A-Tetrahydrocannabinol and ethanol: differential effects on sympathetic activityin differing environmental setting, Seience 180: 1368.
Oates, J.A., Nirenberg, P.Z., Jepson, J.B., Sjverdrma, A., and Undenfriend, S., 1963, Conversion of phenylalanine to phenyl-ethylamine in patients with phenylketonuria, Proc. Soc. Exptl. Biol. and Med. 112: 1078.
Pedemonte, W.A., and Sabel1i, H.C., 1973, Possible direct modulator role of serotonin and its metabolites on sleep mechanisms in newly- hatched chicks, to be presented at the Society for Neuroscienee, San Diego, Nov. 1973.
Prange, Jr., H.J., 1973, The use of drugs in depression: its theoretical and practical basis, Psychiatric Annals 3: 56.
Rodriguez Casanova, E., and Fernandez Labriola, R., 1972, Estudios sobrela Fenetilaminuri a en depresiones, Ann. Biol. Psychiat. 1: 5.
Rothballer, A.B., 1959, The effects of catecholamines on the central nervous system, Pharmacol. Rev. 11: 494.
Saavedra, J.M., and Axel rod, J., 1973, Demonstration and distribution of phenylethanolamine in brain and other tissues, Proc. Nat. Acad. Sci. (USA) 70: 769.
Sabelli, H.C., I960, Pressor effects of adrenergic agents and serotonin after the administration of imipramine, Arzneirn. — Forsch. 10: 935.
Sabelli, H.C., 1964, A pharmacological strategy for the study of central modulator linkages, in “Recent Advances in Biological Psychiatry,” Vol. 6, (J, Wortis, ed.), pp. 145–182, Plenum Press, New York.
Sabelli, H.C., 1970, Optic evoked potential changes induced by de-aminated metabolites of serotonin: 5-Hydroxytryptophol and 5-hydroxyindoleacetic acid, Experientia 26: 58.
Sabelli, H.C., and Giardina, W.J., 1970a, CNS effects of the alde-hyde products of brain monoamines, Biol. Psychiat. 2: 119.
Sabelli, H.C., and Giardina, W.J., 1970b, Tryptaldehydes (Indole-acetaldehydes) in serotonergic sleep of newly hatched chicks, Arzneim. Forsch. 20: 74.
Sabelli, H.C., and Giardina, W.J., 1971, The influence of inhibitors of amine metabolism on the effects of serotonin and its metabolites on the photic evoked potential in rabbits, Experientia 27: 64.
Sabelli, H.C., and Giardina, W.J., 1973a, Evidence for biological activity of deaminated metabolites of catecholamines, presented at the Society of Biological Psychiatry, Montreal, June 8–10.
Sabelli, H.C., and Giardina, W.J., 1973b, Amine modulation of affective behavior, in “Chemical Modulation of Brain Function,” (H.C. Sabelli, ed.), pp. 225–259, Raven Press, New York.
Sabelli, H.C., and Gorosito,M., 1969, Evidence for biogenic amine receptors in toad sciatic nerves, Int. J. Neuropharmacol. 8: 495.
Sabelli, H.C., and Mosnaim, A.D., 1973, Phenyl ethyl amine hypothesis of affective behavior, presented at the American Psychiatric Association, Honolulu, May 7–13, 1973.
Sabelli, H.C., and Toman, J.E.P., 1961, Efectos electrocardiograficos de agentes antidepresivos, Rev. Soc. Argent. Biol. 37: 205.
Sabel1iH.C., Levin, J.J., and Toman, J.E.P., 1961, Mecanismos colinergicos y agentes antidepresivos, Rev. Soc. Argent. Biol. 37: 87.
Sabelli, H.C., Giardina, W.J., Alivisatos, S.G.A., Seth, P.K., and Ungar, F., 1969, Indoleacetaldehydes: Serotonin-like effects on the central nervous system, Nature (Lond.) 223: 73.
Sabelli, H.C., Giardina, W.J., and Alivisatos, S.G.A., 1970, Influ ence of serotonin and related substances upon photic evoked potentials of rabbit: Evidence for biological activity of the aldehyde derivative, Arzneim. Forsch. 20: 68.
Sabelli, H.C., Giardina, W.J., andBartizal, F., 1971a, Photic evoked cortical potentials: Interaction of reserpine, monoamine oxidase inhibition and DOPA, Biol. Psychiat. 3: 273.
Sabelli, H.C., Giardina, W.J., Mosnaim, A.D., and Sabelli, N.H., 1971b, A comparison of the functional roles of norepinephrine, dopamine and phenyl ethyl amine in the central nervous system, Proceedings of the Satellite Symposium “Central and Peripheral Adrenergic Systems” XXV International Congress of Physiological Sciences, Warsaw, August 3–6, 1971.
Sabelli, H.C., Mosnaim, A.D., and Vazquez, A.J., 1973a, Possible role of 2-phenylethyl amine and L-DOPA in extrapyramidal disorders and their drug therapy, to be presented at the American Society for Pharmacology and Experimental Therapeutics, Michigan, August 19–23, 1973.
Sabelli, H.C., Vazquez, A.J., and Flavin, D.F., 1973b, Differential effects of two putative neuromodulators: 2-phenylethyl amine and 2-phenylethanolamine, to be presented at the Society for Neuro-science, San Diego, Nov. 1973.
Sabelli, H.C., Mosnaim, A.D., Vazquez, A.J., and Madrid-Pedemonte, L., 1973c, (-)-Trans-A9-tetrahydrocannabinoi-induced increase in brain 2-phenylethyl amine: its possible role in the psychological effect of marihuana, in “Drug Addiction: Behavioral Aspects,” (J. Singh, ed.), Futura Publishing Co., New York, in press.
Sandler, M., and Youdim, M.B., 1972, Multiple forms of monoamine oxidase: functional significance, Pharmacol. Rev, 24: 331.
Schildkraut, J.J., 1973, Norepinephrine metabolism in the patho-physiology and classification of depressive and manic disorders, in “Psychopathology and Psychopharmacology,” (J.O. Cole, A.Freed- man, and A. Friedhoff, eds.), John Hopkins Press, Baltimore, in press.
Seeman, P., 1972, The membrane actions of anesthetics and tranquilizers, Pharmacol. Rev. 24: 583.
Sulser, F., and Sanders-Bush, E., 1971, Effect of drugs on amines in the CNS, Ann Rev. Pharmacol. 11: 209.
Toman, J.E.P., and Sabel1i, H.C., 1968, Neuropharmacology of earthworm giant fibers, Int. Neuropharmacol. 7: 543.
Vane, J.B., 1960, The actions of sympathomimetic amines on tryptamine receptors, in “Adrenergic Mechanisms (A CIBA Foundation Symposium)” (J.R. Vane, G.E. Wolstenholme, and M. O’Connor, eds.), pp. 356–372, J. and A. Churchill, Ltd., London.
Vazquez, A.J., and Krip, G., 1973, Interactions between amphetamine and serotonergic agents on cat’s isolated cerebral cortex, Biol. Psychiatry 7: 11.
Vazquez, A.J., Giardina, W.J., Madrid-Pedemonte, L., Mosnaim, A.D., and Sabelli, H.C., 1973, Direct role of DOPA in the central nervous system, to be presented at the Society for Neurosei enee, San Diego, Nov. 1973.
Whalley, C., Mosnaim, A.D., and Sabel1i, H.C., 1973, 2-Phenylethylamine in rabbit brain and liver: its synthesis, metabolism and role in the action of imipramine, pargyline, and marihuana, to be presented at the American Society for Pharmacology and Experimental Therapeutics, Michigan, August 19–23, 1973.
Yang, H-YT., and Neff, N.H., 1973, Monoamine oxidase: I. a natural substrate for type B enzyme, Fed. Proc. 32: 797.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Plenum Press, New York
About this chapter
Cite this chapter
Sabelli, H.C., Mosnaim, A.D., Vazquez, A.J. (1974). Phenylethylamine: Possible Role in Depression and Antidepressive Drug Action. In: Myers, R.D., Drucker-Colín, R.R. (eds) Neurohumoral Coding of Brain Function. Advances in Behavioral Biology, vol 10. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3066-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3066-0_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3068-4
Online ISBN: 978-1-4684-3066-0
eBook Packages: Springer Book Archive